Bod gets go-ahead for Schedule 3 CBD trial by Martin Lane January 25, 2022April 29, 2024 Bod Australia has received ethics approval for a phase IIB clinical trial investigating the efficacy of […]
Researchers discover therapeutic potential of CBD for Parkinson’s sufferers by Martin Lane October 11, 2021April 29, 2024
Company news: Bod Australia; Zelira Therapeutics; Creso Pharma; Emyria; AusCann; Allied Corp by Martin Lane September 23, 2021April 26, 2024
Company news: Bod; Emyria; Cann Group; Health House; Releaf Clinics; Creso Pharma; Greenfern; Medlab by Martin Lane August 26, 2021April 26, 2024
Podcast: Bod CEO Jo Patterson on the future of work in a post-Covid world by Martin Lane July 22, 2021May 2, 2024
Bod inks UK distribution deal for new CBII-branded products by Martin Lane June 17, 2021April 26, 2024
